Cargando…

Inflammatory Myofibroblastic Tumor 12 Years After Treatment for Synovial Sarcoma: A Case Report

Inflammatory myofibroblastic tumors (IMTs) are mesenchymal neoplasms most seen in the abdominopelvic region, lung, and retroperitoneum; and less commonly seen in virtually any other site. We report a case of two lower limb masses consistent with diagnosis of IMTs. This is a 39-year-old woman with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Aadit, Pey, Eduard, Achonu, Justice U, Bai, Ji Dong K, Khan, Fazel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495227/
https://www.ncbi.nlm.nih.gov/pubmed/34629909
http://dx.doi.org/10.2147/ORR.S333124
_version_ 1784579497409904640
author Shah, Aadit
Pey, Eduard
Achonu, Justice U
Bai, Ji Dong K
Khan, Fazel
author_facet Shah, Aadit
Pey, Eduard
Achonu, Justice U
Bai, Ji Dong K
Khan, Fazel
author_sort Shah, Aadit
collection PubMed
description Inflammatory myofibroblastic tumors (IMTs) are mesenchymal neoplasms most seen in the abdominopelvic region, lung, and retroperitoneum; and less commonly seen in virtually any other site. We report a case of two lower limb masses consistent with diagnosis of IMTs. This is a 39-year-old woman with a history of right lower extremity popliteal fossa synovial sarcoma diagnosed 12 years prior and treated with chemotherapy, surgery, and radiation. She presented with two new – one anterior and one posterior – right thigh masses. Biopsies of the lesions demonstrated low-grade inflammatory spindle cell lesions at both sites. Wide resection was performed for both masses and further characterization of the surgical specimens was most consistent with IMT. At follow-up, the patient is well with no signs of recurrence 19 and 7 months postoperative to the resection of the anterior and posterior thigh masses, respectively. This case represents the first reported IMTs occurring as late as 12 years after primary cancer treatment, and the first occurring after synovial sarcoma.
format Online
Article
Text
id pubmed-8495227
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84952272021-10-08 Inflammatory Myofibroblastic Tumor 12 Years After Treatment for Synovial Sarcoma: A Case Report Shah, Aadit Pey, Eduard Achonu, Justice U Bai, Ji Dong K Khan, Fazel Orthop Res Rev Case Report Inflammatory myofibroblastic tumors (IMTs) are mesenchymal neoplasms most seen in the abdominopelvic region, lung, and retroperitoneum; and less commonly seen in virtually any other site. We report a case of two lower limb masses consistent with diagnosis of IMTs. This is a 39-year-old woman with a history of right lower extremity popliteal fossa synovial sarcoma diagnosed 12 years prior and treated with chemotherapy, surgery, and radiation. She presented with two new – one anterior and one posterior – right thigh masses. Biopsies of the lesions demonstrated low-grade inflammatory spindle cell lesions at both sites. Wide resection was performed for both masses and further characterization of the surgical specimens was most consistent with IMT. At follow-up, the patient is well with no signs of recurrence 19 and 7 months postoperative to the resection of the anterior and posterior thigh masses, respectively. This case represents the first reported IMTs occurring as late as 12 years after primary cancer treatment, and the first occurring after synovial sarcoma. Dove 2021-10-02 /pmc/articles/PMC8495227/ /pubmed/34629909 http://dx.doi.org/10.2147/ORR.S333124 Text en © 2021 Shah et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Case Report
Shah, Aadit
Pey, Eduard
Achonu, Justice U
Bai, Ji Dong K
Khan, Fazel
Inflammatory Myofibroblastic Tumor 12 Years After Treatment for Synovial Sarcoma: A Case Report
title Inflammatory Myofibroblastic Tumor 12 Years After Treatment for Synovial Sarcoma: A Case Report
title_full Inflammatory Myofibroblastic Tumor 12 Years After Treatment for Synovial Sarcoma: A Case Report
title_fullStr Inflammatory Myofibroblastic Tumor 12 Years After Treatment for Synovial Sarcoma: A Case Report
title_full_unstemmed Inflammatory Myofibroblastic Tumor 12 Years After Treatment for Synovial Sarcoma: A Case Report
title_short Inflammatory Myofibroblastic Tumor 12 Years After Treatment for Synovial Sarcoma: A Case Report
title_sort inflammatory myofibroblastic tumor 12 years after treatment for synovial sarcoma: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495227/
https://www.ncbi.nlm.nih.gov/pubmed/34629909
http://dx.doi.org/10.2147/ORR.S333124
work_keys_str_mv AT shahaadit inflammatorymyofibroblastictumor12yearsaftertreatmentforsynovialsarcomaacasereport
AT peyeduard inflammatorymyofibroblastictumor12yearsaftertreatmentforsynovialsarcomaacasereport
AT achonujusticeu inflammatorymyofibroblastictumor12yearsaftertreatmentforsynovialsarcomaacasereport
AT baijidongk inflammatorymyofibroblastictumor12yearsaftertreatmentforsynovialsarcomaacasereport
AT khanfazel inflammatorymyofibroblastictumor12yearsaftertreatmentforsynovialsarcomaacasereport